Different regulation of cigarette smoke induced inflammation in upper versus lower airways

Respiratory Research

Volumn 11, Issue , 2010, Pages

  Huvenne, Wouter ^a   Pérez Novo, Claudina A ^a   Derycke, Lara ^a   De Ruyck, Natalie ^a   Krysko, Olga ^a   Maes, Tania ^a   Pauwels, Nele ^a   Robays, Lander ^a   Bracke, Ken R ^a   Joos, Guy ^a   Brusselle, Guy ^a   Bachert, Claus ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CIGARETTE SMOKE; GRANULOCYTE CHEMOTACTIC PROTEIN 2; INTERLEUKIN 17; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; AUTACOID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; LONG TERM EXPOSURE; LOWER RESPIRATORY TRACT INFECTION; LUNG; LUNG LAVAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PROTEIN EXPRESSION; T LYMPHOCYTE; TISSUE SECTION; TURBINATE; UPPER RESPIRATORY TRACT INFECTION; ANIMAL; C57BL MOUSE; COMPARATIVE STUDY; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; NOSE; NOSE MUCOSA; PNEUMONIA; POLYMERASE CHAIN REACTION; SMOKING; TIME;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; LUNG; MALE; MICE; MICE, INBRED C57BL; NASAL MUCOSA; NEUTROPHILS; NOSE; PNEUMONIA; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SMOKING; T-LYMPHOCYTES; TIME FACTORS; TURBINATES;

EID: 77956700474     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-11-100     Document Type: Article

References (27)

1. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 2003, 22:672-688. 10.1183/09031936.03.00040703, 14582923.
2. Kim JS, Rubin BK. Nasal and sinus inflammation in chronic obstructive pulmonary disease. COPD 2007, 4:163-166. 10.1080/15412550701341228, 17530509.
3. Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001, 108:S147-334. 10.1067/mai.2001.118891, 11707753.
4. Annesi-Maesano I. Epidemiological evidence of the occurrence of rhinitis and sinusitis in asthmatics. Allergy 1999, 54(Suppl 57):7-13. 10.1111/j.1398-9995.1999.tb04401.x, 10565475.
5. Bousquet J, Vignola AM, Demoly P. Links between rhinitis and asthma. Allergy 2003, 58:691-706. 10.1034/j.1398-9995.2003.00105.x, 12859545.
6. Bracke KR, D Hulst A I, Maes T, Moerloose KB, Demedts IK, Lebecque S, Joos GF, Brusselle GG. Cigarette smoke-induced pulmonary inflammation and emphysema are attenuated in CCR6-deficient mice. J Immunol 2006, 177:4350-4359.
7. Barnes PJ. Chemokines in COPD. Chronic Obstructive Pulmonary Disease 2007, 859-866. Blackwell Publishing, Stockley RA, Rennard SI, Rabe K, Celli B.
8. van der Strate BW, Postma DS, Brandsma CA, Melgert BN, Luinge MA, Geerlings M, Hylkema MN, van den Berg A, Timens W, Kerstjens HA. Cigarette smoke-induced emphysema: A role for the B cell?. Am J Respir Crit Care Med 2006, 173:751-758. 10.1164/rccm.200504-594OC, 16399994.
9. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Pare PD. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004, 350:2645-2653. 10.1056/NEJMoa032158, 15215480.
10. Brusselle GG, Demoor T, Bracke KR, Brandsma CA, Timens W. Lymphoid follicles in (very) severe COPD: beneficial or harmful?. Eur Respir J 2009, 34:219-230. 10.1183/09031936.00150208, 19567605.
11. Grumelli S, Corry DB, Song LZ, Song L, Green L, Huh J, Hacken J, Espada R, Bag R, Lewis DE, Kheradmand F. An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med 2004, 1:e8. 10.1371/journal.pmed.0010008, 523885, 15526056.
12. Curtis JL, Freeman CM, Hogg JC. The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research. Proc Am Thorac Soc 2007, 4:512-521. 10.1513/pats.200701-002FM, 2365762,2365762, 17878463.
13. Hizawa N, Kawaguchi M, Huang SK, Nishimura M. Role of interleukin-17F in chronic inflammatory and allergic lung disease. Clin Exp Allergy 2006, 36:1109-1114. 10.1111/j.1365-2222.2006.02550.x, 16961709.
14. Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 2009, 360:2445-2454. 10.1056/NEJMra0804752, 19494220.
15. Smyth LJ, Starkey C, Vestbo J, Singh D. CD4-regulatory cells in COPD patients. Chest 2007, 132:156-163. 10.1378/chest.07-0083, 17505034.
16. Vachier I, Vignola AM, Chiappara G, Bruno A, Meziane H, Godard P, Bousquet J, Chanez P. Inflammatory features of nasal mucosa in smokers with and without COPD. Thorax 2004, 59:303-307. 10.1136/thx.2003.006650, 1763801, 15047949.
17. Blank U, Ruckes C, Clauss W, Weber WM. Effects of nicotine on human nasal epithelium: evidence for nicotinic receptors in non-excitable cells. Pflugers Arch 1997, 434:581-586. 10.1007/s004240050439, 9242722.
18. Bascom R, Kulle T, Kagey-Sobotka A, Proud D. Upper respiratory tract environmental tobacco smoke sensitivity. Am Rev Respir Dis 1991, 143:1304-1311.
19. Lieu JE, Feinstein AR. Confirmations and surprises in the association of tobacco use with sinusitis. Arch Otolaryngol Head Neck Surg 2000, 126:940-946.
20. Ebbert JO, Croghan IT, Schroeder DR, Murawski J, Hurt RD. Association between respiratory tract diseases and secondhand smoke exposure among never smoking flight attendants: a cross-sectional survey. Environ Health 2007, 6:28. 10.1186/1476-069X-6-28, 2064907, 17897468.
21. Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 2007, 8:R19. 10.1186/gb-2007-8-2-r19, 1852402, 17291332.
22. Chen GY, Chen C, Wang L, Chang X, Zheng P, Liu Y. Cutting edge: Broad expression of the FoxP3 locus in epithelial cells: a caution against early interpretation of fatal inflammatory diseases following in vivo depletion of FoxP3-expressing cells. J Immunol 2008, 180:5163-5166. 2527697, 18390696.
23. D Hulst AI, Maes T, Bracke KR, Demedts IK, Tournoy KG, Joos GF, Brusselle GG. Cigarette smoke-induced pulmonary emphysema in scid-mice. Is the acquired immune system required?. Respir Res 2005, 6:147. 10.1186/1465-9921-6-147, 1334210, 16359546.
24. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, Cua DJ, Littman DR. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006, 126:1121-1133. 10.1016/j.cell.2006.07.035, 16990136.
25. Traves SL, Donnelly LE. Th17 cells in airway diseases. Curr Mol Med 2008, 8:416-426. 10.2174/156652408785160998, 18691069.
26. Barcelo B, Pons J, Ferrer JM, Sauleda J, Fuster A, Agusti AG. Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking. Eur Respir J 2008, 31:555-562. 10.1183/09031936.00010407, 18057064.
27. Askenasy N, Kaminitz A, Yarkoni S. Mechanisms of T regulatory cell function. Autoimmun Rev 2008, 7:370-375. 10.1016/j.autrev.2008.03.001, 18486924.